These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37772733)

  • 1. Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets.
    Laureano de Souza M; Lapierre TJWJD; Vitor de Lima Marques G; Ferraz WR; Penteado AB; Henrique Goulart Trossini G; Murta SMF; de Oliveira RB; de Oliveira Rezende C; Ferreira RS
    Expert Opin Ther Targets; 2023; 27(10):911-925. PubMed ID: 37772733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease.
    Beltran-Hortelano I; Perez-Silanes S; Galiano S
    Curr Med Chem; 2017 May; 24(11):1066-1138. PubMed ID: 28025938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease.
    Beltran-Hortelano I; Alcolea V; Font M; Pérez-Silanes S
    Bioorg Med Chem; 2022 Mar; 58():116577. PubMed ID: 35189560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexes of Trypanosoma cruzi sterol 14α-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: structural basis for pathogen selectivity.
    Hargrove TY; Wawrzak Z; Alexander PW; Chaplin JH; Keenan M; Charman SA; Perez CJ; Waterman MR; Chatelain E; Lepesheva GI
    J Biol Chem; 2013 Nov; 288(44):31602-15. PubMed ID: 24047900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic screening approaches for Chagas disease drug discovery.
    Chatelain E; Ioset JR
    Expert Opin Drug Discov; 2018 Feb; 13(2):141-153. PubMed ID: 29235363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease.
    Riley J; Brand S; Voice M; Caballero I; Calvo D; Read KD
    PLoS Negl Trop Dis; 2015 Sep; 9(9):e0004014. PubMed ID: 26394211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanothione Reductase: A Target for the Development of Anti- Trypanosoma cruzi Drugs.
    Vázquez K; Paulino M; Salas CO; Zarate-Ramos JJ; Vera B; Rivera G
    Mini Rev Med Chem; 2017; 17(11):939-946. PubMed ID: 28302040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.
    Guedes-da-Silva FH; Batista DG; Da Silva CF; De Araújo JS; Pavão BP; Simões-Silva MR; Batista MM; Demarque KC; Moreira OC; Britto C; Lepesheva GI; Soeiro MN
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel drug discovery for Chagas disease.
    Moraes CB; Franco CH
    Expert Opin Drug Discov; 2016; 11(5):447-55. PubMed ID: 26967915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational Methods to Discover Compounds for the Treatment of Chagas Disease.
    Cortés-Ruiz EM; Palomino-Hernández O; Rodríguez-Hernández KD; Espinoza B; Medina-Franco JL
    Adv Protein Chem Struct Biol; 2018; 113():119-142. PubMed ID: 30149904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current advances in drug discovery for Chagas disease.
    Scarim CB; Jornada DH; Chelucci RC; de Almeida L; Dos Santos JL; Chung MC
    Eur J Med Chem; 2018 Jul; 155():824-838. PubMed ID: 30033393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new era for chagas disease drug discovery?
    Keenan M; Chaplin JH
    Prog Med Chem; 2015; 54():185-230. PubMed ID: 25727705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel drugs for Chagas disease: is carbonic anhydrase a target for antiprotozoal drugs?
    Beatriz Vermelho A; Rodrigues GC; Nocentini A; Mansoldo FRP; Supuran CT
    Expert Opin Drug Discov; 2022 Oct; 17(10):1147-1158. PubMed ID: 36039500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological characteristics of the Trypanosoma cruzi Arequipa strain make it a good model for Chagas disease drug discovery.
    Martín-Escolano R; Rosales MJ; Marín C
    Acta Trop; 2022 Dec; 236():106679. PubMed ID: 36096184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The chemotherapy of Chagas disease].
    Stoppani AO
    Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery.
    Ekins S; de Siqueira-Neto JL; McCall LI; Sarker M; Yadav M; Ponder EL; Kallel EA; Kellar D; Chen S; Arkin M; Bunin BA; McKerrow JH; Talcott C
    PLoS Negl Trop Dis; 2015; 9(6):e0003878. PubMed ID: 26114876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of imidazole and benzimidazole heterocycles in Chagas disease: A review.
    Beltran-Hortelano I; Alcolea V; Font M; Pérez-Silanes S
    Eur J Med Chem; 2020 Nov; 206():112692. PubMed ID: 32818869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why hasn't there been more progress in new Chagas disease drug discovery?
    Vermelho AB; Rodrigues GC; Supuran CT
    Expert Opin Drug Discov; 2020 Feb; 15(2):145-158. PubMed ID: 31670987
    [No Abstract]   [Full Text] [Related]  

  • 19. Discovery and Genetic Validation of Chemotherapeutic Targets for Chagas' Disease.
    Osorio-Méndez JF; Cevallos AM
    Front Cell Infect Microbiol; 2018; 8():439. PubMed ID: 30666299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo studies of the antiparasitic activity of sterol 14α-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi.
    Soeiro Mde N; de Souza EM; da Silva CF; Batista Dda G; Batista MM; Pavão BP; Araújo JS; Aiub CA; da Silva PB; Lionel J; Britto C; Kim K; Sulikowski G; Hargrove TY; Waterman MR; Lepesheva GI
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4151-63. PubMed ID: 23774435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.